Jane Street’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jane Street’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,042	Closed	-$1.51M	–	10121
2023 Q3	$1.51M	Sell	13,042 -25,380	-66%	-$2.73M	﹤0.01%	4512
2023 Q2	$3.95M	Sell	38,422 -22,814	-37%	-$2.41M	﹤0.01%	3077
2023 Q1	$6.68M	Sell	61,236 -126,555	-67%	-$14M	﹤0.01%	2074
2022 Q4	$21.4M	Buy	187,791 +110,870	+144%	+$9.21M	0.01%	956
2022 Q3	$4.76M	Sell	76,921 -52,926	-41%	-$3.7M	﹤0.01%	2709
2022 Q2	$10.4M	Buy	129,847 +73,515	+131%	+$6.96M	﹤0.01%	1700
2022 Q1	$5.93M	Sell	56,332 -35,656	-39%	-$3.47M	﹤0.01%	2752
2021 Q4	$9.91M	Buy	91,988 +12,613	+16%	+$1.38M	﹤0.01%	1897
2021 Q3	$8.7M	Sell	79,375 -22,765	-22%	-$2.36M	﹤0.01%	1984
2021 Q2	$9.56M	Sell	102,140 -146,680	-59%	-$13.5M	﹤0.01%	1774
2021 Q1	$22.9M	Buy	248,820 +61,317	+33%	+$5.17M	0.01%	875
2020 Q4	$13.7M	Sell	187,503 -188,954	-50%	-$14M	0.01%	1158
2020 Q3	$29.2M	Buy	376,457 +360,327	+2,234%	+$24.8M	0.02%	592
2020 Q2	$897K	Buy	+16,130	New	+$690K	﹤0.01%	4224
2020 Q1	–	Sell	-57,537	Closed	-$2.08M	–	6415
2019 Q4	$2.08M	Buy	+57,537	New	+$1.76M	﹤0.01%	1897
2019 Q3	–	Sell	-135,362	Closed	-$3.26M	–	6183
2019 Q2	$3.26M	Buy	+135,362	New	+$3.43M	0.01%	1407
2019 Q1	–	Sell	-29,887	Closed	-$584K	–	6015
2018 Q4	$584K	Buy	+29,887	New	+$586K	﹤0.01%	3270
2018 Q2	–	Sell	-12,471	Closed	-$190K	–	5961
2018 Q1	$177K	Sell	12,471 -97,069	-89%	-$1.43M	﹤0.01%	4493
2017 Q4	$1.6M	Buy	109,540 +54,025	+97%	+$759K	﹤0.01%	1806
2017 Q3	$704K	Buy	+55,515	New	+$706K	﹤0.01%	2698
2017 Q2	–	Sell	-16,981	Closed	-$211K	–	5150
2017 Q1	$251K	Sell	16,981 -54,410	-76%	-$881K	﹤0.01%	3633
2016 Q4	$1.16M	Buy	71,391 +57,594	+417%	+$1.04M	0.01%	1897
2016 Q3	$250K	Buy	+13,797	New	+$270K	﹤0.01%	3488
2016 Q2	–	Sell	-78,606	Closed	-$1.27M	–	4860
2016 Q1	$1.3M	Buy	+78,606	New	+$1.38M	0.01%	1600
2015 Q4	–	Sell	-52,745	Closed	-$1.03M	–	4686
2015 Q3	$1.04M	Sell	52,745 -34,298	-39%	-$1.08M	0.01%	1592
2015 Q2	$3.02M	Buy	87,043 +8,422	+11%	+$257K	0.02%	731
2015 Q1	$2.04M	Buy	+78,621	New	+$1.44M	0.02%	853
2014 Q4	–	Sell	-46,049	Closed	-$565K	–	3277
2014 Q3	$565K	Sell	46,049 -39,850	-46%	-$463K	0.01%	1329
2014 Q2	$1.36M	Buy	+85,899	New	+$1.23M	0.02%	724
2014 Q1	–	Sell	-28,421	Closed	-$217K	–	3240
2013 Q4	$217K	Buy	+28,421	New	+$153K	﹤0.01%	1959

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jane Street's HZNP Position: Q4 2023 in Review

Jane Street sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 13,042 shares — an estimated $1.51M sold.

Jane Street first reported a position in HZNP in Q4 2013 and held it in 30 quarters. The position peaked at $29.2M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Jane Street reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Jane Street sold 13,042 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.51M.
Jane Street first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 30 quarters.
Jane Street's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $29.2M in Q3 2020.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.